Literature DB >> 21726641

Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: the importance of the entry pathway.

Diego Delgado1, Ana del Pozo-Rodríguez, Maria Ángeles Solinís, Alicia Rodríguez-Gascón.   

Abstract

The aim of our study was to evaluate the effect of protamine on the transfection capacity of solid lipid nanoparticles (SLNs) by correlating it to the internalization mechanisms and intracellular trafficking of the vectors. Vectors were prepared with SLN, DNA, and protamine. ARPE-19 and HEK-293 cells were used for the evaluation of the formulations. Protamine induced a 6-fold increase in the transfection of SLNs in retinal cells due to the presence of nuclear localization signals (NLS), its protection capacity, and a shift in the internalization mechanism from caveolae/raft-mediated to clathrin-mediated endocytosis. However, protamine produced an almost complete inhibition of transfection in HEK-293 cells. In spite of the high DNA condensation capacity of protamine and its content in NLS, this does not always lead to an improvement in cell transfection since it may impair some of the limiting steps of the transfection processes.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21726641     DOI: 10.1016/j.ejpb.2011.06.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  17 in total

1.  Chitosan-based hybrid nanocomplex for siRNA delivery and its application for cancer therapy.

Authors:  Min-Hyo Ki; Ji-Eon Kim; Young-Nam Lee; Sang Myoung Noh; Sung-Won An; Hyun-Jong Cho; Dae-Duk Kim
Journal:  Pharm Res       Date:  2014-05-24       Impact factor: 4.200

2.  Nanovectorization of DNA Through Cells Using Protamine Complexation.

Authors:  Khaoula Boukari; Cécile Caoduro; Raoudha Kacem; Nadia Skandrani; Christophe Borg; Hatem Boulahdour; Tijani Gharbi; Régis Delage-Mourroux; Eric Hervouet; Marc Pudlo; Fabien Picaud
Journal:  J Membr Biol       Date:  2016-03-24       Impact factor: 1.843

Review 3.  Endocytosis in gene therapy with non-viral vectors.

Authors:  Aritz Perez Ruiz de Garibay
Journal:  Wien Med Wochenschr       Date:  2016-05-03

Review 4.  Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

Authors:  Rahel Zulliger; Shannon M Conley; Muna I Naash
Journal:  J Control Release       Date:  2015-10-09       Impact factor: 9.776

5.  Intracellular trafficking and exocytosis of a multi-component siRNA nanocomplex.

Authors:  Ravi S Shukla; Akshay Jain; Zhen Zhao; Kun Cheng
Journal:  Nanomedicine       Date:  2016-03-10       Impact factor: 5.307

Review 6.  Protamine-Based Strategies for RNA Transfection.

Authors:  Natalia Teresa Jarzebska; Mark Mellett; Julia Frei; Thomas M Kündig; Steve Pascolo
Journal:  Pharmaceutics       Date:  2021-06-14       Impact factor: 6.321

Review 7.  Lipid Nanoparticles for Ocular Gene Delivery.

Authors:  Yuhong Wang; Ammaji Rajala; Raju V S Rajala
Journal:  J Funct Biomater       Date:  2015-06-08

Review 8.  Peptides used in the delivery of small noncoding RNA.

Authors:  Ravi S Shukla; Bin Qin; Kun Cheng
Journal:  Mol Pharm       Date:  2014-09-08       Impact factor: 4.939

9.  Multicomponent nanoparticles as nonviral vectors for the treatment of Fabry disease by gene therapy.

Authors:  Aritz Pérez Ruiz de Garibay; Diego Delgado; Ana Del Pozo-Rodríguez; María Ángeles Solinís; Alicia Rodríguez Gascón
Journal:  Drug Des Devel Ther       Date:  2012-10-26       Impact factor: 4.162

Review 10.  Development of nucleic acid vaccines: use of self-amplifying RNA in lipid nanoparticles.

Authors:  Alicia Rodríguez-Gascón; Ana del Pozo-Rodríguez; María Ángeles Solinís
Journal:  Int J Nanomedicine       Date:  2014-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.